Drug Class
DPP-4 inhibitor and biguanide combination
Type
brand
Active Ingredient
linagliptin
Educational overview only. This page summarizes publicly available information about Jentadueto for general understanding. For full prescribing details, consult official labeling or a healthcare professional.
📋Overview
Jentadueto is a combination therapy consisting of linagliptin and metformin. These two components work through different mechanisms to help regulate blood sugar levels. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin is a biguanide.
This dual-action approach targets multiple pathways in the body to assist in glucose management.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Jentadueto
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.
